Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal prophylactic enoxaparin dosing in critically ill ICU patients - part 2
2010-022034-88Phase 4Completed
- Sponsor
- University Hospital Odense
- Start
- Aug 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of enoxaparin in venous thromboembolism (VTE) (4 arms), sponsored by University Hospital Odense. Primary endpoint: Anti-Xa activity. Started Aug 2010; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2010-022034-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022034-88.